title: Effect of retinoic acid on cell proliferation and differentiation as well as on lipid synthesis, lipoprotein secretion, and apolipoprotein biogenesis.
abstract: Dietary vitamin A and its active metabolites are essential nutrients for many functions as well as potent regulators of gene transcription and growth. Although the epithelium of the small intestine is characterized by rapid and constant renewal and enterocytes play a central role in the absorption and metabolism of alimentary retinol, very little is known about the function of retinoids in the human gastrointestinal epithelium and mechanisms by which programs engage the cell cycle are poorly understood. We have assessed the effects of 10 microM 9- and 13-cis-retinoic acid (RA) on proliferation and differentiation processes, lipid esterification, apolipoprotein (apo) biogenesis and lipoprotein secretion along with nuclear factor gene transcription. Treatment of Caco-2 cells with RA at different concentrations and incubation periods revealed the reduction of thymidine incorporation in 60% preconfluent or 100% confluent cells. Concomitantly, RA 1) modulated D-type cyclins by reducing the mitogen-sensitive cyclin D1 and upregulating cyclin D3 expressions and 2) caused a trend of increase in p38 MAPK, which triggers CDX2, a central protein in cell differentiation. RA remained without effect on lipoprotein output and apo synthesis, even for apo A-I that possesses RARE in its promoter. RA, in combination with 22-hydroxycholesterol, could induce apo A-I gene expression without any impact on apo A-I mass. Only the gene expression of peroxisome proliferator-activated receptor (PPAR)beta, retinoic receptor (RAR)beta, and RARgamma was augmented and no alteration was noted in PPARalpha, PPARgamma, liver X receptor (LXR)alpha, LXRbeta, and retinoid X receptors. Taken together, these data highlight RA-induced cell differentiation via specific signaling without a significant impact on apo A-I synthesis.
authors.affiliation: Department of Nutrition, Université de Montréal, Montréal, Québec, Canada. emile.levy@recherche-ste-justine.qc.ca
authors.forename: Emilie
authors.initials: E
authors.lastname: Grenier
authors.forename: Françoise Schwalm
authors.initials: FS
authors.lastname: Maupas
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Beaulieu
authors.forename: Ernest
authors.initials: E
authors.lastname: Seidman
authors.forename: Edgard
authors.initials: E
authors.lastname: Delvin
authors.forename: Alain
authors.initials: A
authors.lastname: Sane
authors.forename: Eric
authors.initials: E
authors.lastname: Tremblay
authors.forename: Carole
authors.initials: C
authors.lastname: Garofalo
authors.forename: Emile
authors.initials: E
authors.lastname: Levy
mesh_terms: D001053:Apolipoproteins / Q000096:biosynthesis*; D018938:Caco-2 Cells; D002454:Cell Differentiation / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects*; D008074:Lipoproteins / Q000378:metabolism*; D014212:Tretinoin / Q000008:administration & dosage*
chemical_list: D001053:Apolipoproteins; D008074:Lipoproteins; D014212:Tretinoin